Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 59OTHER 47NIH 14NETWORK 9UNKNOWN 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 4Leiomyoma 3Lung Neoplasms 2Lipoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Barrett Esophagus 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Overweight 1Osteosarcoma 1Obesity 1Neutropenia 1Neoplasms, Squamous Cell 1Melanoma 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Leiomyomatosis 1Inflammatory Bowel Diseases 1Hypotrichosis 1Fibrosis 1Craniopharyngioma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Cancer Cachexia 1

Interventions

pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × INDIV × Neutropenia × Clear all
NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡